Research On Pharmaceutical Enterprise Intellectual Property Strategy Management System

In the 21st century,high-tech advances,new technology advances and knowledge-based economy have emerged.Human,material and financial resources,are the three main operating "business resources" and intellectual property is the fourth largest.Intellectual property development,protection,operations has become key factors in regional and national transactions and has gained advantage in competition,in that the quantity and quality of intellectual property rights for self-development in terms of competitiveness is an important measure.At the moment,economic globalization continues to widen and deepen the intellectual property as an important non-tariff barrier,and have gradually become an important factor affecting enterprises to participate in international competition.Intellectual property strategies,policies for enterprises have successfully entered the international market to provide support and protection.Because pharmaceutical companies are highly dependent on intellectual property,pharmaceutical companies improve IPR creation,use,development and protection of the ability to implement the strategic management of intellectual property rights and have become pharmaceutical company's responsibility to explore the domestic market and gain market advantage of the inevitable choice.In this paper,the theory of intellectual property management,corporate.strategic management theory,corporate competitiveness theory and system engineering theory etc.are the theoretical basis of suggesting the establishment of China's pharmaceutical enterprises Intellectual Property Strategic Management System.Construction-Operational Mechanism-Evaluation theoretical framework,application system engineering theory and methods from intellectual development,intellectual property protection and intellectual property rights are used to build the three pharmaceutical company's operational strategic management of intellectual property rights,system and in-depth analysis designed the pharmaceutical companies operating mechanisms of intellectual property strategic management system,including the system of dynamic mechanism,benefit distribution mechanisms,coordination mechanism,incentive and restraint mechanisms.The effect of influencing factors on pharmaceutical company's strategic management of intellectual property systems analysis,operations from intellectual development,intellectual property protection and intellectual property rights are used to build three dimensional pharmaceutical companies intellectual property,strategy,operational results from primary evaluation system management systems.The use of group eigenvalue method for identifying key indicators,building and effective evaluation index system affects pharmaceutical intellectual Property strategic Management system,builds the strategic management of intellectual property-based pharmaceutical companies in the DEA-Malmquist Index Approach systems,running effective evaluation model,as opposed to existing static results of research.The effect of introducing the DEA-Malmquist Index Approach on pharmaceutical companies operating on IP strategy management system for dynamic evaluation,improves the selection of 2005-2010 China's 29 provincial-level regions pharmaceutical companies panel data from the region.The overall perspective of pharmaceutical enterprises in Heilongjiang Province based on strategic management of intellectual property systems operating in various regions of empirical evaluation studies,and empirical results of in-depth analysis,pharmaceutical companies seeking to suppress the strategic management of intellectual property rights factors roots system.Intellectual property laws and regulations improves IPR enforcement efforts,and supporting policies,strengthening social awareness of intellectual property rights,intellectual property management departments to strengthen management,and promote international-exchange and cooperation to enhance corporate intellectual property and development capabilities.The ability to institutionalize the management of intellectual property rights,enhance its efforts to bring pharmaceutical companies intellectual property personnel and other aspects of intellectual property strategy to improve the management of Chinese en erprises pharmaceutical countermeasures.